Logo image of CHR-DB-B.CA

CHORUS AVIATION INC (CHR-DB-B.CA) Stock Fundamental Analysis

Canada - TSX:CHR-DB-B - CA17040TAE25

100.4 CAD
+0.39 (+0.39%)
Last: 9/24/2025, 7:00:00 PM
Fundamental Rating

4

Overall CHR-DB-B gets a fundamental rating of 4 out of 10. We evaluated CHR-DB-B against 7 industry peers in the Passenger Airlines industry. CHR-DB-B has only an average score on both its financial health and profitability. CHR-DB-B is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHR-DB-B had positive earnings in the past year.
CHR-DB-B had a positive operating cash flow in the past year.
In multiple years CHR-DB-B reported negative net income over the last 5 years.
In the past 5 years CHR-DB-B always reported a positive cash flow from operatings.
CHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFCHR-DB-B.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

1.2 Ratios

CHR-DB-B has a worse Return On Assets (-1.91%) than 75.00% of its industry peers.
CHR-DB-B has a worse Return On Equity (-4.82%) than 62.50% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.54%, CHR-DB-B belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for CHR-DB-B is in line with the industry average of 5.73%.
The 3 year average ROIC (5.30%) for CHR-DB-B is below the current ROIC(6.54%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROIC 6.54%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
CHR-DB-B.CA Yearly ROA, ROE, ROICCHR-DB-B.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60 80

1.3 Margins

Looking at the Operating Margin, with a value of 6.87%, CHR-DB-B is in line with its industry, outperforming 50.00% of the companies in the same industry.
In the last couple of years the Operating Margin of CHR-DB-B has declined.
Looking at the Gross Margin, with a value of 65.48%, CHR-DB-B belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
CHR-DB-B's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 6.87%
PM (TTM) N/A
GM 65.48%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
CHR-DB-B.CA Yearly Profit, Operating, Gross MarginsCHR-DB-B.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CHR-DB-B is destroying value.
The number of shares outstanding for CHR-DB-B has been reduced compared to 1 year ago.
The number of shares outstanding for CHR-DB-B has been increased compared to 5 years ago.
Compared to 1 year ago, CHR-DB-B has an improved debt to assets ratio.
CHR-DB-B.CA Yearly Shares OutstandingCHR-DB-B.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
CHR-DB-B.CA Yearly Total Debt VS Total AssetsCHR-DB-B.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

CHR-DB-B has an Altman-Z score of 2.38. This is not the best score and indicates that CHR-DB-B is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.38, CHR-DB-B belongs to the top of the industry, outperforming 87.50% of the companies in the same industry.
CHR-DB-B has a debt to FCF ratio of 7.89. This is a slightly negative value and a sign of low solvency as CHR-DB-B would need 7.89 years to pay back of all of its debts.
CHR-DB-B has a Debt to FCF ratio of 7.89. This is amongst the best in the industry. CHR-DB-B outperforms 87.50% of its industry peers.
A Debt/Equity ratio of 0.54 indicates that CHR-DB-B is somewhat dependend on debt financing.
CHR-DB-B has a better Debt to Equity ratio (0.54) than 87.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Altman-Z 2.38
ROIC/WACC0.75
WACC8.76%
CHR-DB-B.CA Yearly LT Debt VS Equity VS FCFCHR-DB-B.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.14 indicates that CHR-DB-B should not have too much problems paying its short term obligations.
CHR-DB-B's Current ratio of 1.14 is on the low side compared to the rest of the industry. CHR-DB-B is outperformed by 62.50% of its industry peers.
A Quick Ratio of 0.61 indicates that CHR-DB-B may have some problems paying its short term obligations.
CHR-DB-B's Quick ratio of 0.61 is on the low side compared to the rest of the industry. CHR-DB-B is outperformed by 75.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.14
Quick Ratio 0.61
CHR-DB-B.CA Yearly Current Assets VS Current LiabilitesCHR-DB-B.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

CHR-DB-B shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 78.57%, which is quite impressive.
The earnings per share for CHR-DB-B have been decreasing by -19.03% on average. This is quite bad
The Revenue for CHR-DB-B has decreased by -13.36% in the past year. This is quite bad
Measured over the past years, CHR-DB-B shows a small growth in Revenue. The Revenue has been growing by 0.56% on average per year.
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%

3.2 Future

CHR-DB-B is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 1.21% yearly.
The Revenue is expected to decrease by -5.14% on average over the next years.
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CHR-DB-B.CA Yearly Revenue VS EstimatesCHR-DB-B.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
CHR-DB-B.CA Yearly EPS VS EstimatesCHR-DB-B.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 44.62 indicates a quite expensive valuation of CHR-DB-B.
CHR-DB-B's Price/Earnings ratio is a bit more expensive when compared to the industry. CHR-DB-B is more expensive than 62.50% of the companies in the same industry.
When comparing the Price/Earnings ratio of CHR-DB-B to the average of the S&P500 Index (25.67), we can say CHR-DB-B is valued expensively.
Based on the Price/Forward Earnings ratio of 52.09, the valuation of CHR-DB-B can be described as expensive.
CHR-DB-B's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. CHR-DB-B is more expensive than 62.50% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 31.86. CHR-DB-B is valued rather expensively when compared to this.
Industry RankSector Rank
PE 44.62
Fwd PE 52.09
CHR-DB-B.CA Price Earnings VS Forward Price EarningsCHR-DB-B.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CHR-DB-B is valued a bit more expensive than 75.00% of the companies in the same industry.
CHR-DB-B's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. CHR-DB-B is cheaper than 62.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 52.76
EV/EBITDA 13.62
CHR-DB-B.CA Per share dataCHR-DB-B.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.81
PEG (5Y)N/A
EPS Next 2Y12.98%
EPS Next 3Y1.21%

2

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.42%, CHR-DB-B has a reasonable but not impressive dividend return.
CHR-DB-B's Dividend Yield is a higher than the industry average which is at 2.41.
Compared to an average S&P500 Dividend Yield of 2.40, CHR-DB-B's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.42%

5.2 History

The dividend of CHR-DB-B is nicely growing with an annual growth rate of 21.58%!
CHR-DB-B is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)21.58%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of CHR-DB-B are negative and hence is the payout ratio. CHR-DB-B will probably not be able to sustain this dividend level.
The dividend of CHR-DB-B is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP-34.57%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
CHR-DB-B.CA Yearly Income VS Free CF VS DividendCHR-DB-B.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M -600M

CHORUS AVIATION INC

TSX:CHR-DB-B (9/24/2025, 7:00:00 PM)

100.4

+0.39 (+0.39%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupTransportation
GICS IndustryPassenger Airlines
Earnings (Last)08-05 2025-08-05/amc
Earnings (Next)11-06 2025-11-06/amc
Inst Owners3.2%
Inst Owner ChangeN/A
Ins Owners1.35%
Ins Owner ChangeN/A
Market Cap2.57B
Revenue(TTM)1.37B
Net Income(TTM)-25.87M
Analysts78
Price Target133.9 (33.37%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.42%
Yearly Dividend0.98
Dividend Growth(5Y)21.58%
DP-34.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.45%
Min EPS beat(2)3.87%
Max EPS beat(2)11.03%
EPS beat(4)4
Avg EPS beat(4)62.09%
Min EPS beat(4)3.87%
Max EPS beat(4)207.96%
EPS beat(8)5
Avg EPS beat(8)11.1%
EPS beat(12)6
Avg EPS beat(12)4.98%
EPS beat(16)8
Avg EPS beat(16)3.11%
Revenue beat(2)0
Avg Revenue beat(2)-6.13%
Min Revenue beat(2)-8.31%
Max Revenue beat(2)-3.95%
Revenue beat(4)0
Avg Revenue beat(4)-6%
Min Revenue beat(4)-8.31%
Max Revenue beat(4)-3.78%
Revenue beat(8)3
Avg Revenue beat(8)-2.48%
Revenue beat(12)5
Avg Revenue beat(12)-1.45%
Revenue beat(16)8
Avg Revenue beat(16)1.16%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-1.03%
EPS NQ rev (3m)-5.64%
EPS NY rev (1m)0%
EPS NY rev (3m)-4.29%
Revenue NQ rev (1m)-0.89%
Revenue NQ rev (3m)-2.85%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.63%
Valuation
Industry RankSector Rank
PE 44.62
Fwd PE 52.09
P/S 1.88
P/FCF 52.76
P/OCF 30.38
P/B 4.78
P/tB 4.86
EV/EBITDA 13.62
EPS(TTM)2.25
EY2.24%
EPS(NY)1.93
Fwd EY1.92%
FCF(TTM)1.9
FCFY1.9%
OCF(TTM)3.3
OCFY3.29%
SpS53.45
BVpS20.99
TBVpS20.65
PEG (NY)0.81
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.91%
ROE -4.82%
ROCE 8.82%
ROIC 6.54%
ROICexc 6.9%
ROICexgc 6.96%
OM 6.87%
PM (TTM) N/A
GM 65.48%
FCFM 3.56%
ROA(3y)-4.73%
ROA(5y)-2.72%
ROE(3y)-14.73%
ROE(5y)-8.13%
ROIC(3y)5.3%
ROIC(5y)4.78%
ROICexc(3y)5.99%
ROICexc(5y)5.28%
ROICexgc(3y)6.05%
ROICexgc(5y)5.32%
ROCE(3y)7.14%
ROCE(5y)6.44%
ROICexgc growth 3Y33.52%
ROICexgc growth 5Y7.31%
ROICexc growth 3Y33.18%
ROICexc growth 5Y7.15%
OM growth 3Y-18.7%
OM growth 5Y-14.78%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.38%
GM growth 5Y-2.24%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.54
Debt/FCF 7.89
Debt/EBITDA 1.36
Cap/Depr 30.21%
Cap/Sales 2.62%
Interest Coverage 2.06
Cash Conversion 39.75%
Profit Quality N/A
Current Ratio 1.14
Quick Ratio 0.61
Altman-Z 2.38
F-Score5
WACC8.76%
ROIC/WACC0.75
Cap/Depr(3y)31.44%
Cap/Depr(5y)62.49%
Cap/Sales(3y)3.58%
Cap/Sales(5y)12.17%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)78.57%
EPS 3Y-16.46%
EPS 5Y-19.03%
EPS Q2Q%842.86%
EPS Next Y55.31%
EPS Next 2Y12.98%
EPS Next 3Y1.21%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.36%
Revenue growth 3Y11.15%
Revenue growth 5Y0.56%
Sales Q2Q%-7.58%
Revenue Next Year-4.85%
Revenue Next 2Y-3.49%
Revenue Next 3Y-5.14%
Revenue Next 5YN/A
EBIT growth 1Y-53.02%
EBIT growth 3Y-9.64%
EBIT growth 5Y-14.31%
EBIT Next Year86.18%
EBIT Next 3Y12.53%
EBIT Next 5YN/A
FCF growth 1Y-79.47%
FCF growth 3Y24.37%
FCF growth 5YN/A
OCF growth 1Y-70.44%
OCF growth 3Y12.73%
OCF growth 5Y0.25%

CHORUS AVIATION INC / CHR-DB-B.CA FAQ

Can you provide the ChartMill fundamental rating for CHORUS AVIATION INC?

ChartMill assigns a fundamental rating of 4 / 10 to CHR-DB-B.CA.


What is the valuation status of CHORUS AVIATION INC (CHR-DB-B.CA) stock?

ChartMill assigns a valuation rating of 2 / 10 to CHORUS AVIATION INC (CHR-DB-B.CA). This can be considered as Overvalued.


Can you provide the profitability details for CHORUS AVIATION INC?

CHORUS AVIATION INC (CHR-DB-B.CA) has a profitability rating of 4 / 10.


Can you provide the financial health for CHR-DB-B stock?

The financial health rating of CHORUS AVIATION INC (CHR-DB-B.CA) is 5 / 10.


Can you provide the expected EPS growth for CHR-DB-B stock?

The Earnings per Share (EPS) of CHORUS AVIATION INC (CHR-DB-B.CA) is expected to grow by 55.31% in the next year.